RPG Life Sciences (RPGLIFE.BO) Earnings Analysis
RPG Life Sciences (RPGLIFE.BO) has no confirmed upcoming earnings date. Last quarter (2026-04-27) it beat with EPS 18.08 INR vs 4.46 INR est (+305.4%). It has beaten estimates in 5/6 recent quarters (83%). Trailing P/E 41.73.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does RPGLIFE.BO next report earnings?
No confirmed upcoming earnings date is currently scheduled for RPGLIFE.BO. This page updates as the calendar is published.
RPGLIFE.BO earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-27 | 18.08 INR | 4.46 INR | +305.4% | Beat |
| 2026-01-22 | 13.38 INR | 3.87 INR | +245.7% | Beat |
| 2025-07-25 | 15.9 INR | 3.87 INR | +310.9% | Beat |
| 2025-04-28 | 70.95 INR | 4.46 INR | +1490.8% | Beat |
| 2025-01-24 | 21.12 INR | 3.87 INR | +445.7% | Beat |
| 2024-11-07 | 2.54 INR | 3.87 INR | -34.4% | Miss |
Beat rate: 5/6 (83%) over reported quarters with consensus data.
RPGLIFE.BO valuation and analyst view
| Trailing P/E | 41.73 |
|---|---|
| Trailing EPS | 69.64 INR |
| Price / book | 7.94 |
| Dividend yield | 0.83% |
| Market cap | 50.23B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is RPG Life Sciences (RPGLIFE.BO)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for RPGLIFE.BO. This page updates as the calendar is published.
Did RPGLIFE.BO beat earnings last quarter?
In its 2026-04-27 report, RPGLIFE.BO posted EPS of 18.08 INR versus a 4.46 INR estimate — a beat of 305.4%.
What is RPGLIFE.BO's earnings track record?
Over the last 6 reported quarters with consensus data, RPGLIFE.BO beat estimates 5 times (83%).
What is RPGLIFE.BO's current P/E ratio and EPS?
RPGLIFE.BO trades at a trailing P/E of 41.73 on trailing EPS of 69.63961784980046 INR.
What do analysts rate RPGLIFE.BO?
RPGLIFE.BO has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.